Stemness & Metastasis: Advances in Research and Clinical Translation
20-21 May 2021

Janine Erler

Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Denmark

Prof Janine Erler is a tenured full Professor in cancer biology at the Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Denmark, where she researches how the tumour microenvironment drives cancer progression.

Janine obtained a BSc (Hons) in 2000 in Molecular Genetics in Biotechnology from the University of Sussex, UK. She then obtained a PhD in 2003 in Molecular Pharmacology from the University of Manchester, UK, researching how tumour hypoxia drives chemoresistance. After this, Janine did her post-doctoral training at Stanford University for four years where she continued her research on hypoxia but now focused on how this drives metastasis. She then returned to the UK in 2008 to set up her own lab at the Institute of Cancer Research, and moved her lab to BRIC in Denmark in 2012.

She is Founder and CEO of a start-up company developing new anti-cancer therapies, spun out of her lab at the University of Copenhagen. Janine also heads a programme for precision medicine for cancer patients at the main hospital in Denmark (Rigshospitalet) together with her clinical partner Prof Ulrik Lassen (head of Oncology). 

Janine has received many honors and awards for her work, and is an elected member of the Danish Royal Academy of Sciences and Letters.